| Case report : From sequence to solution: tailoring treatment for transformed follicular lymphoma (DLBCL) through next generation sequencing study | Frontiers in oncology |  | | 2024 | 85 | 100 |
|
| Effectiveness of fractionated rituximab in preventing tumor lysis syndrome in aggressive B-cell lymphoma : Insights from real-life clinical practice | Cancer reports | | | 2024 | 75 | 651 |
|
| Nab-PIPAC: a phase IB study protocol of intraperitoneal cisplatin and nab-paclitaxel administered by pressurised intraperitoneal aerosol chemotherapy (PIPAC) in the treatment of advanced malignancies confined to the peritoneal cavity | BMJ open | | | 2023 | 504 | 119 |
|
| L'agranulocytose liée à la chimiothérapie comme facteur prédictif des mutations germinales BRCA1 chez les patientes atteintes d'un cancer du sein | | | | 2023 | 219 | 128 |
|
| Efficacy of immune checkpoint blockade and biomarkers of response in lymphoma: a narrative review | Biomedicines | | | 2023 | 103 | 359 |
|
| CAR T-Based Therapies in Lymphoma: A Review of Current Practice and Perspectives | Biomedicines | | | 2022 | 231 | 405 |
|
| Traitements intrapéritonéaux de la carcinose ovarienne : proposition d’algorithmes décisionnels | Revue médicale suisse | | | 2022 | 170 | 127 |
|
| Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes | Scientific Reports | | | 2020 | 340 | 388 |
|
